BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 25111817)

  • 1. Genetic architecture of type 2 diabetes.
    Hara K; Shojima N; Hosoe J; Kadowaki T
    Biochem Biophys Res Commun; 2014 Sep; 452(2):213-20. PubMed ID: 25111817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferability of type 2 diabetes implicated loci in multi-ethnic cohorts from Southeast Asia.
    Sim X; Ong RT; Suo C; Tay WT; Liu J; Ng DP; Boehnke M; Chia KS; Wong TY; Seielstad M; Teo YY; Tai ES
    PLoS Genet; 2011 Apr; 7(4):e1001363. PubMed ID: 21490949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes and polymorphisms on chromosome 9p21: a meta-analysis.
    Cugino D; Gianfagna F; Santimone I; de Gaetano G; Donati MB; Iacoviello L; Di Castelnuovo A
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):619-25. PubMed ID: 21315566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential promoter activity by nucleotide substitution at a type 2 diabetes genome-wide association study signal upstream of the wolframin gene.
    Ryu J; Lee C
    J Diabetes; 2016 Mar; 8(2):253-9. PubMed ID: 25800097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in understanding the genetic architecture of type 2 diabetes.
    Mohlke KL; Boehnke M
    Hum Mol Genet; 2015 Oct; 24(R1):R85-92. PubMed ID: 26160912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of linkage disequilibrium in different populations: implications and opportunities for lipid-associated loci identified from genome-wide association studies.
    Teo YY; Sim X
    Curr Opin Lipidol; 2010 Apr; 21(2):104-15. PubMed ID: 20125009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association studies and type 2 diabetes.
    Wheeler E; Barroso I
    Brief Funct Genomics; 2011 Mar; 10(2):52-60. PubMed ID: 21436302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NEUROG3 variants and type 2 diabetes in Italians.
    Milord E; Gragnoli C
    Minerva Med; 2006 Oct; 97(5):373-8. PubMed ID: 17146417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci.
    Gaulton KJ; Ferreira T; Lee Y; Raimondo A; Mägi R; Reschen ME; Mahajan A; Locke A; Rayner NW; Robertson N; Scott RA; Prokopenko I; Scott LJ; Green T; Sparso T; Thuillier D; Yengo L; Grallert H; Wahl S; Frånberg M; Strawbridge RJ; Kestler H; Chheda H; Eisele L; Gustafsson S; Steinthorsdottir V; Thorleifsson G; Qi L; Karssen LC; van Leeuwen EM; Willems SM; Li M; Chen H; Fuchsberger C; Kwan P; Ma C; Linderman M; Lu Y; Thomsen SK; Rundle JK; Beer NL; van de Bunt M; Chalisey A; Kang HM; Voight BF; Abecasis GR; Almgren P; Baldassarre D; Balkau B; Benediktsson R; Blüher M; Boeing H; Bonnycastle LL; Bottinger EP; Burtt NP; Carey J; Charpentier G; Chines PS; Cornelis MC; Couper DJ; Crenshaw AT; van Dam RM; Doney AS; Dorkhan M; Edkins S; Eriksson JG; Esko T; Eury E; Fadista J; Flannick J; Fontanillas P; Fox C; Franks PW; Gertow K; Gieger C; Gigante B; Gottesman O; Grant GB; Grarup N; Groves CJ; Hassinen M; Have CT; Herder C; Holmen OL; Hreidarsson AB; Humphries SE; Hunter DJ; Jackson AU; Jonsson A; Jørgensen ME; Jørgensen T; Kao WH; Kerrison ND; Kinnunen L; Klopp N; Kong A; Kovacs P; Kraft P; Kravic J; Langford C; Leander K; Liang L; Lichtner P; Lindgren CM; Lindholm E; Linneberg A; Liu CT; Lobbens S; Luan J; Lyssenko V; Männistö S; McLeod O; Meyer J; Mihailov E; Mirza G; Mühleisen TW; Müller-Nurasyid M; Navarro C; Nöthen MM; Oskolkov NN; Owen KR; Palli D; Pechlivanis S; Peltonen L; Perry JR; Platou CG; Roden M; Ruderfer D; Rybin D; van der Schouw YT; Sennblad B; Sigurðsson G; Stančáková A; Steinbach G; Storm P; Strauch K; Stringham HM; Sun Q; Thorand B; Tikkanen E; Tonjes A; Trakalo J; Tremoli E; Tuomi T; Wennauer R; Wiltshire S; Wood AR; Zeggini E; Dunham I; Birney E; Pasquali L; Ferrer J; Loos RJ; Dupuis J; Florez JC; Boerwinkle E; Pankow JS; van Duijn C; Sijbrands E; Meigs JB; Hu FB; Thorsteinsdottir U; Stefansson K; Lakka TA; Rauramaa R; Stumvoll M; Pedersen NL; Lind L; Keinanen-Kiukaanniemi SM; Korpi-Hyövälti E; Saaristo TE; Saltevo J; Kuusisto J; Laakso M; Metspalu A; Erbel R; Jöcke KH; Moebus S; Ripatti S; Salomaa V; Ingelsson E; Boehm BO; Bergman RN; Collins FS; Mohlke KL; Koistinen H; Tuomilehto J; Hveem K; Njølstad I; Deloukas P; Donnelly PJ; Frayling TM; Hattersley AT; de Faire U; Hamsten A; Illig T; Peters A; Cauchi S; Sladek R; Froguel P; Hansen T; Pedersen O; Morris AD; Palmer CN; Kathiresan S; Melander O; Nilsson PM; Groop LC; Barroso I; Langenberg C; Wareham NJ; O'Callaghan CA; Gloyn AL; Altshuler D; Boehnke M; Teslovich TM; McCarthy MI; Morris AP;
    Nat Genet; 2015 Dec; 47(12):1415-25. PubMed ID: 26551672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps.
    Mahajan A; Taliun D; Thurner M; Robertson NR; Torres JM; Rayner NW; Payne AJ; Steinthorsdottir V; Scott RA; Grarup N; Cook JP; Schmidt EM; Wuttke M; Sarnowski C; Mägi R; Nano J; Gieger C; Trompet S; Lecoeur C; Preuss MH; Prins BP; Guo X; Bielak LF; Below JE; Bowden DW; Chambers JC; Kim YJ; Ng MCY; Petty LE; Sim X; Zhang W; Bennett AJ; Bork-Jensen J; Brummett CM; Canouil M; Ec Kardt KU; Fischer K; Kardia SLR; Kronenberg F; Läll K; Liu CT; Locke AE; Luan J; Ntalla I; Nylander V; Schönherr S; Schurmann C; Yengo L; Bottinger EP; Brandslund I; Christensen C; Dedoussis G; Florez JC; Ford I; Franco OH; Frayling TM; Giedraitis V; Hackinger S; Hattersley AT; Herder C; Ikram MA; Ingelsson M; Jørgensen ME; Jørgensen T; Kriebel J; Kuusisto J; Ligthart S; Lindgren CM; Linneberg A; Lyssenko V; Mamakou V; Meitinger T; Mohlke KL; Morris AD; Nadkarni G; Pankow JS; Peters A; Sattar N; Stančáková A; Strauch K; Taylor KD; Thorand B; Thorleifsson G; Thorsteinsdottir U; Tuomilehto J; Witte DR; Dupuis J; Peyser PA; Zeggini E; Loos RJF; Froguel P; Ingelsson E; Lind L; Groop L; Laakso M; Collins FS; Jukema JW; Palmer CNA; Grallert H; Metspalu A; Dehghan A; Köttgen A; Abecasis GR; Meigs JB; Rotter JI; Marchini J; Pedersen O; Hansen T; Langenberg C; Wareham NJ; Stefansson K; Gloyn AL; Morris AP; Boehnke M; McCarthy MI
    Nat Genet; 2018 Nov; 50(11):1505-1513. PubMed ID: 30297969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHOP T/C and C/T haplotypes contribute to early-onset type 2 diabetes in Italians.
    Gragnoli C
    J Cell Physiol; 2008 Nov; 217(2):291-5. PubMed ID: 18680108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic markers of type 2 diabetes: Progress in genome-wide association studies and clinical application for risk prediction.
    Wang X; Strizich G; Hu Y; Wang T; Kaplan RC; Qi Q
    J Diabetes; 2016 Jan; 8(1):24-35. PubMed ID: 26119161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional annotation of sixty-five type-2 diabetes risk SNPs and its application in risk prediction.
    Wu Y; Jing R; Dong Y; Kuang Q; Li Y; Huang Z; Gan W; Xue Y; Li Y; Li M
    Sci Rep; 2017 Mar; 7():43709. PubMed ID: 28262806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing the association of novel meta-analysis-derived diabetes risk genes with type II diabetes and related metabolic traits in Asian Indian Sikhs.
    Sanghera DK; Been L; Ortega L; Wander GS; Mehra NK; Aston CE; Mulvihill JJ; Ralhan S
    J Hum Genet; 2009 Mar; 54(3):162-8. PubMed ID: 19247373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of Type 2 Diabetes in African Americans.
    Ng MC
    Curr Diab Rep; 2015 Oct; 15(10):74. PubMed ID: 26285759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in defining the genetic contribution to type 2 diabetes susceptibility.
    Morris AP
    Curr Opin Genet Dev; 2018 Jun; 50():41-51. PubMed ID: 29477131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSMD9 gene in the NIDDM2 locus is linked to type 2 diabetes in Italians.
    Gragnoli C
    J Cell Physiol; 2010 Feb; 222(2):265-7. PubMed ID: 19877155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multi-omic Integrative Scheme Characterizes Tissues of Action at Loci Associated with Type 2 Diabetes.
    Torres JM; Abdalla M; Payne A; Fernandez-Tajes J; Thurner M; Nylander V; Gloyn AL; Mahajan A; McCarthy MI
    Am J Hum Genet; 2020 Dec; 107(6):1011-1028. PubMed ID: 33186544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Resolution Genetic Maps Identify Multiple Type 2 Diabetes Loci at Regulatory Hotspots in African Americans and Europeans.
    Lau W; Andrew T; Maniatis N
    Am J Hum Genet; 2017 May; 100(5):803-816. PubMed ID: 28475862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 diabetes risk alleles demonstrate extreme directional differentiation among human populations, compared to other diseases.
    Chen R; Corona E; Sikora M; Dudley JT; Morgan AA; Moreno-Estrada A; Nilsen GB; Ruau D; Lincoln SE; Bustamante CD; Butte AJ
    PLoS Genet; 2012; 8(4):e1002621. PubMed ID: 22511877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.